Top segments and regional performance

Last year, the company generated ‪82.80 B‬ INR, the most of which — ‪36.90 B‬ INR — came from its top-performing segment, Radiopharma, compared to ‪33.88 B‬ INR the previous year. The greatest contribution came from Americas and Europe, which accounted for ‪76.07 B‬ INR last year, with ‪65.94 B‬ INR the year before.